450 research outputs found

    sj-jpg-2-inc-10.1177_17511437231202898 – Supplemental material for Dynamic dosing for continuous renal replacement therapy: Service evaluation of the safety and effectiveness of titrating dose to biochemistry

    No full text
    Supplemental material, sj-jpg-2-inc-10.1177_17511437231202898 for Dynamic dosing for continuous renal replacement therapy: Service evaluation of the safety and effectiveness of titrating dose to biochemistry by Jack C Eldridge, Aroon Bhardwaj Shah, Susana Lucena-Amaro, Christopher J Kirwan, John R Prowle and Yize I Wan in Journal of the Intensive Care Society</p

    sj-jpg-3-inc-10.1177_17511437231202898 – Supplemental material for Dynamic dosing for continuous renal replacement therapy: Service evaluation of the safety and effectiveness of titrating dose to biochemistry

    No full text
    Supplemental material, sj-jpg-3-inc-10.1177_17511437231202898 for Dynamic dosing for continuous renal replacement therapy: Service evaluation of the safety and effectiveness of titrating dose to biochemistry by Jack C Eldridge, Aroon Bhardwaj Shah, Susana Lucena-Amaro, Christopher J Kirwan, John R Prowle and Yize I Wan in Journal of the Intensive Care Society</p

    sj-docx-1-inc-10.1177_17511437231202898 – Supplemental material for Dynamic dosing for continuous renal replacement therapy: Service evaluation of the safety and effectiveness of titrating dose to biochemistry

    No full text
    Supplemental material, sj-docx-1-inc-10.1177_17511437231202898 for Dynamic dosing for continuous renal replacement therapy: Service evaluation of the safety and effectiveness of titrating dose to biochemistry by Jack C Eldridge, Aroon Bhardwaj Shah, Susana Lucena-Amaro, Christopher J Kirwan, John R Prowle and Yize I Wan in Journal of the Intensive Care Society</p

    Standardizing end points in perioperative trials: Towards a core and extended outcome set

    No full text
    COMPAC-StEP Group members include: J. Bartoszko, W. S. Beattie, R. Bellomo, D. Buggy, L. Cabrini, J. Canet, T. Cook, D. J. Cooper, T. Corcoran, P. J. Devereaux, R. Eckenhoff, L. Evered, T. J. Gan, T. Gin, H. Grocott, G. Haller, S. Howell, M. Jayarajah, C. Kalkman, K. Karkouti, B. Kavanagh, A. Klein, G. Landoni, K. Leslie, D. R. McIlroy, D. Mazer, A. Moller, M. Mythen, M. Neuman, M. Neuman, R. Pearse, P. Peyton, J. Prowle, T. Richards, D. A. Scott, D. Sessler, A. Shaw, T. Short, M. Shulman, B. Silbert, M. Singer, J. R. Sneyd, D. Story, D. van Dijk, and W. van Klei

    Recent Trials in Critical Care Nephrology

    No full text
    Several large observational studies or randomized controlled trials in the field of critical care nephrology have been completed and reported, or recently completed or have recently begun recruitment. These studies provide important information to guide our appreciation of current practice and consider new potentially effective intervention for the prevention or attenuation of acute kidney injury or suggest new avenues for the use of renal replacement therapy (RRT) in the treatment of sepsis. In particular, two studies, the ATN study and the RENAL study (both multicenter randomized controlled trials of >1,000 patients) provide, for the first time, level I evidence to guide the practice of RRT in critically ill patients and to better define the optimal intensity of such RAT in this setting. Clinicians practicing in the field of critical care nephrology need to be aware of these trials, their details, their findings or design or current recruitment rate and likely time of completion to continue to offer their patients the highest level of evidence-based medical care. Copyright (C) 2010 S. Karger AG, Base

    Re-balancing the roles of public and private health sectors in Wales

    No full text
    In 1989 the UK implemented a form of political devolution to Wales, Scotland and Northern Ireland such that certain public policy areas, including health, became the responsibility of devolved Parliament or Assemblies and not the London based Parliament and Government. In the case of Wales, the Welsh Government is faced with a series of daunting challenges in relation to the future provision of health care but, unlike the situation in England, has rejected any significant increase in the involvement of the private sector in health care provision. The magnitude of the challenges faced in coping with the impacts of financial austerity on the Welsh health budget suggest there may be a role for the private sector to play in relation to the provision of health care in Wales. This paper explores those potential roles concerning: the supply of services to the NHS in Wales, the supply of health services to the Welsh population and the financing of Welsh health services
    corecore